Northwestern Mutual Wealth Management’s Maravai LifeSciences MRVI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,500	Closed	-$7.08K	–	4327
2026 Q1	$7.08K	Buy	+2,500	New	+$8.48K	﹤0.01%	3190
2025 Q4	–	Sell	-1,842	Closed	-$5.29K	–	4169
2025 Q3	$5.29K	Buy	+1,842	New	+$4.7K	﹤0.01%	3129
2024 Q4	–	Sell	-888	Closed	-$7.38K	–	3791
2024 Q3	$7.38K	Buy	+888	New	+$7.68K	﹤0.01%	2794
2024 Q2	–	Sell	-43	Closed	-$373	–	3700
2024 Q1	$373	Sell	43 -7	-14%	-$47	﹤0.01%	3338
2023 Q4	$328	Buy	+50	New	+$323	﹤0.01%	3316
2023 Q2	–	Sell	-37	Closed	-$518	–	3509
2023 Q1	$518	Buy	37 +21	+131%	+$302	﹤0.01%	3103
2022 Q4	$229	Buy	+16	New	+$252	﹤0.01%	3175
2021 Q2	–	Sell	-218	Closed	-$8K	–	3108
2021 Q1	$8K	Buy	+218	New	+$7.22K	﹤0.01%	2351

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Northwestern Mutual Wealth Management's MRVI Position: Q2 2026 in Review

Northwestern Mutual Wealth Management sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 2,500 shares — an estimated $7.08K sold.

Northwestern Mutual Wealth Management first reported a position in MRVI in Q1 2021 and held it in 8 quarters. The position peaked at $8K in Q1 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Northwestern Mutual Wealth Management reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 2,500 Maravai LifeSciences shares in Q2 2026, an estimated $7.08K.
Northwestern Mutual Wealth Management first reported a position in Maravai LifeSciences in Q1 2021 and held it in 8 quarters.
Northwestern Mutual Wealth Management's Maravai LifeSciences position peaked at $8K in Q1 2021.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.